- Drug Manufacturers - General
- Healthcare
Johnson & Johnson
JNJ · US ·
NYSE
160.62
USD
+0.4
(0.25%)
-
15.70
EPS
-
10.23
P/E
-
387B
MARKET CAP
-
2.99%
DIV YIELD
EPS Estimates
| 2023-12-31 | 2024-12-31 | 2025-12-31 | 2026-12-31 | 2027-12-31 | 2028-12-31 | CAGR | |
|---|---|---|---|---|---|---|---|
| High Estimate | 6.79 | 10.5 | 9.81 | 10.4 | 11.8 | 12.4 | 12.86% |
| Avg. Estimate | 6.72 | 10 | 9.14 | 9.77 | 11.7 | 12.3 | 12.86% |
| Low Estimate | 6.59 | 9.91 | 8.39 | 8.78 | 11.5 | 12.1 | 12.86% |
| No. Of Analysts | 9 | 14 | 11 | 4 | 1 | 2 |
Revenue Estimates
| 2023-12-31 | 2024-12-31 | 2025-12-31 | 2026-12-31 | 2027-12-31 | 2028-12-31 | CAGR | |
|---|---|---|---|---|---|---|---|
| High Estimate | 86.6B | 88.7B | 91.7B | 95B | 98.8B | 105B | 3.84% |
| Avg. Estimate | 86.6B | 88.5B | 91.1B | 94.4B | 98.1B | 104B | 3.70% |
| Low Estimate | 86.6B | 88.2B | 90.5B | 92.9B | 96.6B | 102B | 3.37% |
| No. Of Analysts | 13 | 12 | 14 | 16 | 14 | 13 |
Net Income Estimates
| 2023-12-31 | 2024-12-31 | 2025-12-31 | 2026-12-31 | 2027-12-31 | 2028-12-31 | CAGR | |
|---|---|---|---|---|---|---|---|
| High Estimate | 19.7B | 26.9B | 25.1B | 26.6B | 30.3B | 31.8B | 10.11% |
| Avg. Estimate | 16.4B | 25.6B | 21.3B | 22.7B | 30B | 31.5B | 13.99% |
| Low Estimate | 13.1B | 25.4B | 21.5B | 22.5B | 29.4B | 30.9B | 18.69% |
| No. Of Analysts | 13 | 12 | 14 | 16 | 14 | 13 |